Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Li, J; Armstrong, AJ

Published Date

  • May 2015

Published In

Volume / Issue

  • 13 / 5

Start / End Page

  • 293 - 298

PubMed ID

  • 26352773

Pubmed Central ID

  • 26352773

International Standard Serial Number (ISSN)

  • 1543-0790

Language

  • eng

Conference Location

  • United States